NEW YORK (GenomeWeb News) – Shares of Illumina reached an all-time high of $91.41 in Wednesday trade on the Nasdaq before pulling back slightly to close at $90.10.
Meanwhile, Sequenom's shares hit a 52-week high of $17.52 during Wednesday trade, also on the Nasdaq, before closing at $17.37.
Illumina’s shares have been rising steadily over the past few weeks in advance of its second-quarter results being released later this month.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Associated Press reports that gene-edited food may soon be for sale.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.